WASHINGTON – Dr. Anthony Fauci predicts that it will be an “open season” for vaccinations in the US in April, as the promotion of the offer enables most people to get shots to protect against covid-19.
Fauci, who serves as scientific adviser to President Joe Biden of NBC’s Today Show, says the vaccination rate will accelerate significantly in the coming months. He acknowledges the forthcoming deliveries of the two approved vaccines, the possible approval of a third and the steps the Biden government has taken to increase the country’s ability to deliver doses.
He says, “by the time we are in April,” it will be ‘open season, namely anyone and everyone in any category can start vaccinating.’
He warned that it would take several more months to give injections to adult Americans, but the prediction of herd immunity could be reached by late summer.
In other popular news
The head of the World Health Organization for Europe says he is launching a $ 48.5 million program with the European Union to help deploy covid-19 vaccines in six countries that were once Soviet republics.
Dr. Hans Kluge, who has also highlighted a decline in coronavirus cases in recent weeks while the number of warnings remains too high, says the program complements the work through an existing EU program and the WHO-supported COVAX facility aimed at is to use vaccines for all countries in need, whether rich or poor.
The program will involve Armenia, Azerbaijan, Belarus, Georgia, Ukraine and Moldova.
Vaccinations provide a way to emerge faster from this pandemic. But only if we ensure that all countries, regardless of income level, have access to it, ‘Kluge told reporters from Copenhagen, Denmark.
‘Unfair access to vaccines could catch fire again. The longer the virus lingers, the greater the risk of dangerous mutations, ”he added.
Kluge applauded ‘good news’ that new infections in the WTO region of 53 countries have been declining for four consecutive weeks, saying deaths related to covidity have dropped over the past two weeks. He also pointed to declining hospitalization rates.
In the region, about 7.8 million people have completed their vaccination, Kluge said.
In Kenya
The president of Tanzania denies that covid-19 is in his country, but the WTO says that two travelers from Tanzania have been found to be the virus that currently prevails in South Africa.
WHO head of Africa, Matshidiso Moeti, tells reporters that the travelers are to the UK. She again urged the government of Tanzania to share information about the pandemic, and she considers Tanzania to be one of the eight African countries that have the variant.
The country in East Africa has not updated its number of virus cases since April, and populist President John Magufuli not only claimed that God helped defeat covid-19 there, but also expressed doubts about the vaccines.
The U.S. embassy on Wednesday reported a “significant increase” in the number of covid-19 cases in Tanzania since last month, without any details. The Catholic Church in Tanzania has also explicitly warned that covid-19 is present and the citizens are encouraged to take precautions.
In London
AstraZeneca said on Thursday it is working with the University of Oxford to adapt its covid-19 vaccine to protect against new strains of the virus, as public health officials are concerned about mutations that could make the virus more resistant to existing ones. vaccines.
The Anglo-Swedish drugmaker has partnered with Oxford to develop one of the first covid-19 vaccines to be approved for widespread use. AstraZeneca said it hopes to reduce the time required to produce large quantities of new vaccine between six and nine months.
The comment comes when Astra-Zeneca says fourth-quarter net income rose to $ 1.01 billion from $ 313 million in the same quarter a year earlier. Sales of medicines increased by 11% to $ 7.41 billion, driven by a 24% increase in cancer treatments.
The company posted $ 2 million in revenue from its covid-19 vaccine, which it promised to deliver on a non-profit basis during the pandemic.
Categories:
Coronavirus | News | Top stories